Table 3.

Expression of three selected miRNA among different AML subgroup

	miR-181a-2	P *	miR-25	P *	miR-362	P *
Risk category a
Favorable	11.58 ± 0.71	0.046	15.08 ± 0.55	0.004	3.32 ± 1.22	0.001
Intermediate	10.78 ± 1.54		14.55 ± 0.66		4.36 ± 1.09
Poor	11.15 ± 0.98		14.59 ± 0.54		4.29 ± 0.96
FAB morphologyb
M0 Undifferentiated	11.94 ± 0.73	< 0.001	14.95 ± 0.41	0.079	3.88 ± 1.11	< 0.001
M1	11.12 ± 1.32		14.61 ± 0.61		3.88 ± 1.15
M2	11.34 ± 1.13		14.77 ± 0.60		3.52 ± 1.07
M4	10.66 ± 1.17		14.54 ± 0.65		4.73 ± 1.02
M5	9.70 ± 1.99		14.27 ± 0.70		5.02 ± 0.77
M6	11.57 ± 1.07		14.67 ± 1.18		5.25 ± 0.04
M7	10.93 ± 1.09		14.57 ± 1.00		4.53 ± 0.35

^aRisk information of two cases were missing in the TCGA data

^bFAB morphology information of one living patient was missing